STOCK TITAN

Raytech (NASDAQ: RAY) expands into personal health care electronics with new chairman

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Raytech Holding Limited is shifting its strategy toward services for personal health care electronics, including product design, development, and consultation, led by subsidiary Raytech Innovation Limited. The legacy personal care electrical appliances trading business via Pure Beauty Manufacturing will continue, while Worry Free Group remains the Group’s independent marketing solutions arm.

To support this pivot, Raytech has appointed Mr. Haoyuan Liu as Chairman and Executive Director, effective April 15, 2026, adding fintech, capital markets, and regulatory experience to the leadership team alongside Executive Director Mr. Ching Tim Hoi. The company reported cash and cash equivalents of HK$121.5 million (US$15.6 million) as of September 30, 2025, which it highlights as providing capacity to execute the new strategy. Management is targeting the fast‑growing Asia Pacific wearable medical devices segment, cited at US$12.55 billion in 2025 and projected to reach US$26.83 billion by 2030, and views the new services platform as its main growth engine.

Positive

  • None.

Negative

  • None.

Insights

Raytech is pivoting into health-tech services with new leadership and cash to fund the shift.

Raytech is moving from a primarily trading-based personal care appliance business toward a services model in personal health care electronics. This is anchored in Raytech Innovation Limited, which will provide design, development, and consulting services, while the legacy Pure Beauty trading arm and Worry Free marketing subsidiary continue operating.

The company cites cash and cash equivalents of HK$121.5 million (about US$15.6 million) as of September 30, 2025, giving it room to invest in this expansion. Management is targeting the Asia Pacific wearable medical devices segment, described as a US$12.55 billion market in 2025 projected to grow to US$26.83 billion by 2030 at a 16.42% CAGR, though actual outcomes depend on execution and market share.

Leadership has been strengthened with the appointment of Haoyuan Liu as Chairman and Executive Director, effective April 15, 2026, adding fintech and capital markets experience. Future disclosures will clarify how quickly the services business ramps relative to the legacy trading operations and what financial contribution it makes to the Group.

Cash and cash equivalents HK$121.5 million (US$15.6 million) As of September 30, 2025, per prior interim report
Asia Pacific wearable medical devices market 2025 US$12.55 billion Cited core segment of personal health care electronics
Projected market size 2030 US$26.83 billion Asia Pacific wearable medical devices projection by 2030
Market CAGR 16.42% Compound annual growth rate 2025–2030 for Asia Pacific wearable medical devices
Registration statement reference Form F-3 No. 333-290696 6-K contents incorporated by reference into Form F-3
personal health care electronics financial
"strategic expansion of its business focus toward providing services in relation to personal health care electronics"
wearable medical devices financial
"the Asia Pacific wearable medical devices market, a core segment of personal health care electronics"
Wearable medical devices are small tools worn on the body—like patches, smartwatches, or sensor bands—that monitor, diagnose or deliver simple treatments by collecting health data continuously or on demand. They matter to investors because their ability to produce ongoing data, reduce hospital visits, and win regulatory and insurance approval can drive steady revenue, broaden market reach and change how healthcare is delivered, much like a personal health meter or coach.
compound annual growth rate (CAGR) financial
"representing a compound annual growth rate (CAGR) of 16.42%1"
Compound annual growth rate (CAGR) shows how much an investment grows, on average, each year over a certain period. It’s like measuring how fast a plant grows each year, smoothing out the ups and downs to see the overall growth trend. Investors use CAGR to compare different investments and see which one has the best long-term performance.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
registration statement on Form F-3 regulatory
"incorporated by reference into the Company’s registration statement on Form F-3 (Registration No. 333-290696)"
A registration statement on Form F-3 is a streamlined filing used by eligible foreign companies to register securities for sale in the U.S., often as a “shelf” that lets them offer shares quickly when market conditions are right. For investors it matters because it signals that the company can raise capital on short notice—potentially increasing liquidity but also the risk of share dilution if new stock is issued—similar to a company keeping a pre-approved credit line ready to use.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2026

 

Commission File Number: 001-42100

 

RAYTECH HOLDING LIMITED

(Exact name of registrant as specified in its charter)

 

Unit 609, 6/F, Nan Fung Commercial Centre,

No.19 Lam Lok Street, Kowloon Bay, Hong Kong

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

 

 

 

 

Strategic Expansion into Personal Health Care Electronics Sector

 

The Raytech Holding Limited (the “Company”) is expanding its strategic focus toward the personal health care electronics sector. This expansion involves providing services in product design, development, and consultation, intended to capitalize on the growing market demand for wellness technology.

 

In connection with this expansion, the Company has a key personnel development. As previously disclosed in the Form 6-K filed with the Securities And Exchange Commission on April 15, 2026, the Company has announced the appointment of Mr. Haoyuan Liu as its new Chairman of the Board of Director and Executive Director, effective as of April 15, 2026. Mr. Liu has work experiences that highly suited to guiding the Company through its next phase of growth.

 

On April 20, 2026, the Company issued a press release. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

The contents of this Report on Form 6-K are hereby incorporated by reference into the Company’s registration statement on Form F-3 (Registration No. 333-290696) of the Company, that was initially filed with the SEC on October 3, 2025, and declared effective by the SEC on December 18, 2025.

 

1

 

 

Exhibits

 

Exhibit No.   Description
99.1   Press Release

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Raytech Holding Limited
     
Date: April 21, 2026 By: /s/ Tim Hoi Ching
  Name:  Tim Hoi Ching
  Title: Chief Executive Officer

 

3

 

Exhibit 99.1

 

Raytech Holding Limited Announces Strategic Expansion into Personal Health Care Electronics Services; Strengthens Leadership by Appointing Mr. Haoyuan Liu as Chairman and Executive Director

 

HONG KONG, April 20, 2026 /GLOBE NEWSWIRE/ Raytech Holding Limited (NASDAQ: RAY) (“RAY” or the “Company”) today announced a strategic expansion of its business focus toward providing services in relation to personal health care electronics, including product design, development, and consultations, a business development path that has been actively planned and implemented since the third quarter of its financial year ended March 31, 2026 (“FYE2026”).

 

To lead this strategic growth, the Company also announced the appointment of Mr. Haoyuan Liu as its new Chairman of the Board of Director and Executive Director, strengthening its leadership team, effective as of April 15, 2026. As disclosed in the Company’s interim report on Form 6-K, the Company maintained cash and cash equivalents of HK$121.5 million (US$15.6 million) as of September 30, 2025, providing financial capacity to execute this strategic direction.

 

Strategic Expansion into Personal Health Care Electronics Services

 

The Company is executing a deliberate strategic expansion into a services-oriented business line in personal health care electronics. This growth plan is being led by Raytech Innovation Limited, a wholly-owned subsidiary of the Company, which will focus on product design, development, and consultations in relation to personal health care electronics, leveraging the Company and its subsidiaries’ (the “Group”) established expertise in personal care electrical appliances, leveraging the Group’s established expertise in personal care electrical appliances built through its legacy trading arm. That is, Pure Beauty Manufacturing Company Limited, which will continue to operate in an ordinary-course capacity.

 

Worry Free Group (Hong Kong) Limited, a marketing solutions company that was 100% acquired by Raytech Innovation Limited on December 29, 2025 (as previously disclosed), will continue to operate independently as the Group’s marketing solutions subsidiary, sharing relevant experience and best practices to support the growth of Raytech Innovation Limited.

 

Market Opportunity

 

The Company believes the personal health care electronics market presents a compelling long-term growth opportunity driven by rising consumer demand for wellness technology. According to Mordor Intelligence, the Asia Pacific wearable medical devices market, a core segment of personal health care electronics, reached approximately US$12.55 billion in 2025 and is projected to grow to US$26.83 billion by 2030, representing a compound annual growth rate (CAGR) of 16.42%1. RAY is positioning itself to capture a meaningful share of this high-growth market by providing design, development, and consultation services to this sector through Raytech Innovation Limited.

 

Strengthening the Board and Leadership Team

 

Mr. Liu most recently served as Chief Operating Officer of GoFintech Innovation Limited (HKEX: 0290.HK), a financial technology investment platform, and brings extensive experience in fintech operations, capital markets, and regulatory compliance across Hong Kong, Singapore, and the United States — a multidisciplinary background highly suited to guiding the Company through its next phase of growth. Full biographical details will be set out in a separate announcement to be issued today.

 

 

1 Source: Mordor Intelligence. Market data is based on third-party research and is included for illustrative purposes only. There can be no assurance that the market will grow as projected or that the Company will achieve any particular share of this market.

 

 

 

Mr. Ching Tim Hoi continues in his key role as Executive Director. The Board is confident that the combined expertise of Mr. Liu and Mr. Ching creates a powerful leadership dynamic. Mr. Ching’s deep institutional knowledge and operational leadership remain central to the Company’s strategy, ensuring a seamless and effective execution of our growth plans.

 

Management Commentary

 

Mr. Haoyuan Liu, Chairman and Executive Director of the Company, commented: “It is a great honour to join Raytech Holding Limited as Chairman and Executive Director at such an exciting inflection point for the Company. My vision is to build Raytech Innovation Limited into a recognised provider of design, development, and consultation services for personal health care electronics — a sector where I believe Asia Pacific will lead global growth over the next decade. Raytech Innovation Limited will be the engine of this master plan, and I am committed to ensuring our services create genuine, differentiated value for our clients and partners in this high-growth segment. I am equally committed to nurturing the complementary strengths of Worry Free Group and the established foundation of Pure Beauty, so that together we build a more resilient, more focused, and more valuable Group for our shareholders.”

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied, including but not limited to risks related to the execution of the Company’s business strategy, market acceptance of new product/services offerings, the ability to attract and retain key personnel, regulatory developments in Hong Kong and other relevant jurisdictions, and general market and economic conditions. The Company undertakes no obligation to update or revise these forward-looking statements, except as required by applicable law. For a full discussion of risk factors, please refer to the Company’s filings with the U.S. Securities and Exchange Commission (SEC).

 

About Raytech Holding Limited

 

Raytech Holding Limited (NASDAQ: RAY) is a Hong Kong-based holding company with over 10 years of industry experience. The Group operates its established personal care electrical appliances trading business through its subsidiary, Pure Beauty Manufacturing Company Limited. Leveraging its industry expertise, the Company is expanding its focus to include design, development, and consultation services for the personal health care electronics sector, led by its subsidiary Raytech Innovation Limited. Marketing solutions are provided independently by its subsidiary Worry Free Group (Hong Kong) Limited. A Form 6-K in connection with this announcement has been or will be furnished to the SEC.

 

Investor Relations Contact

 

International Elite Capital

Annabelle Zhang
Tel: +1 (646) 866-7928
Email: annabelle@iecapitalusa.com

 

 

FAQ

What strategic change is Raytech Holding Limited (RAY) making?

Raytech is expanding its focus into personal health care electronics services. It plans to offer product design, development, and consultation through Raytech Innovation Limited, while keeping its existing personal care electrical appliances trading and marketing solutions businesses operating under Pure Beauty and Worry Free Group.

How is Raytech (RAY) funding its move into personal health care electronics?

Raytech highlights cash and cash equivalents of HK$121.5 million (US$15.6 million). This balance, reported as of September 30, 2025 in an earlier interim report, provides financial capacity to support investment in the new personal health care electronics services strategy and related growth initiatives.

Who is the new chairman of Raytech Holding Limited (RAY)?

Raytech appointed Mr. Haoyuan Liu as Chairman of the Board and Executive Director, effective April 15, 2026. He brings experience in fintech operations, capital markets, and regulatory compliance across multiple markets, which the company views as well suited to guiding its next phase of strategic growth.

Which subsidiaries will drive Raytech’s (RAY) new strategy?

Raytech Innovation Limited will lead design, development, and consultation services for personal health care electronics. Pure Beauty Manufacturing continues the established personal care electrical appliances trading business, while Worry Free Group (Hong Kong) Limited remains the Group’s marketing solutions subsidiary, sharing expertise to support Raytech Innovation’s expansion.

What market opportunity is Raytech (RAY) targeting with its expansion?

Raytech is targeting the Asia Pacific wearable medical devices market, a core part of personal health care electronics. Citing Mordor Intelligence, this market was about US$12.55 billion in 2025 and is projected to reach US$26.83 billion by 2030, implying a 16.42% compound annual growth rate.

Does Raytech’s (RAY) legacy trading business continue after this strategic shift?

Yes. The company states that Pure Beauty Manufacturing Company Limited, its legacy trading arm for personal care electrical appliances, will continue normal operations. The new services business in personal health care electronics is positioned as an additional growth engine rather than a replacement for the existing trading activities.

Filing Exhibits & Attachments

1 document